Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Naval Submarine Medical Research Laboratory, Groton, CT, United States.
Nitric Oxide. 2017 Sep 30;69:1-9. doi: 10.1016/j.niox.2017.07.001. Epub 2017 Jul 3.
A reduction in oxygen transport contributes to impaired exercise capacity at high altitude. Since blood flow is mediated, in part, by nitric oxide (NO), we hypothesized that sodium nitrate provided before forearm grip exercise performed at a simulated altitude of 4300 m (hypobaric hypoxia (HH)) would increase forearm blood flow and oxygenation, and decrease the decrement in grip performance. In a double-blind, randomized crossover study, 10 healthy subjects (9 males and 1 female) performed continuous (CGrip) and repeated rhythmic (RGrip) isometric forearm exercise until task failure in normobaric normoxia (NN), 2.5 h following consumption of placebo and sodium nitrate (15 mmol) in HH, and then again post-HH at sea-level pressure. Measurements included forearm blood flow (FBF) and anterior forearm tissue oxygenation (StO), mean arterial blood pressure (MAP), arterial blood O saturation (SpO), plasma NO reaction products (NO) and nitrite, and exhaled NO (PE). Compared to baseline testing in NN, performing CGrip and RGrip exercise in HH resulted in significant reductions in forearm blood flow, SaO and StO, responses that were accompanied by significant performance decrements (∼10%) in both CGrip and RGrip exercise. In spite of a 10-fold increase in plasma NO levels and a significant decrease in MAP during CGrip exercise following nitrate consumption, there were no significant main effects of treatment (placebo vs. sodium nitrate) for forearm blood flow, SpO, StO or grip performance. PE remained unchanged between NN, HH and post-HH conditions with placebo, but increased (∼24%) following nitrate supplementation in HH and post-HH. These data do not support a benefit in consuming a single dose of supplemental nitrate on forearm blood flow and isometric exercise in healthy adults at a simulated altitude of 4300 m.
氧气输送减少导致在高海拔地区运动能力受损。由于一氧化氮(NO)部分介导了血流,因此我们假设在模拟海拔 4300 米(低气压缺氧(HH))下进行前臂握力运动前服用硝酸钠会增加前臂血流量和氧合,减少握力表现的下降。在一项双盲、随机交叉研究中,10 名健康受试者(9 名男性和 1 名女性)在常氧常压(NN)下进行连续(CGrip)和重复节奏(RGrip)等长前臂运动,直到任务失败,然后在 HH 中消耗安慰剂和硝酸钠(15 mmol)后 2.5 小时,以及再次在海平面压力下进行 HH 后。测量包括前臂血流量(FBF)和前臂前组织氧合(StO)、平均动脉血压(MAP)、动脉血氧饱和度(SaO)、血浆一氧化氮反应产物(NO)和亚硝酸盐以及呼气一氧化氮(PE)。与 NN 中的基线测试相比,在 HH 中进行 CGrip 和 RGrip 运动导致前臂血流量、SaO 和 StO 显著降低,这些反应伴随着 CGrip 和 RGrip 运动的显著性能下降(约 10%)。尽管在服用硝酸盐后 CGrip 运动期间血浆 NO 水平增加了 10 倍,MAP 显著降低,但前臂血流量、SaO、StO 或握力表现的治疗(安慰剂与硝酸钠)无显著主要影响。PE 在 NN、HH 和 HH 后条件下的安慰剂之间保持不变,但在 HH 和 HH 后补充硝酸盐后增加(约 24%)。这些数据不支持在模拟海拔 4300 米的健康成年人中单次补充硝酸盐对前臂血流量和等长运动的益处。